Quarterly report (Form 10-Q)
Edwards Lifesciences 10-Q for Quarter ended Mar 31, 2026
Filing excerpt
In February 2026, we acquired Autus Valve Technologies, Inc. (“Autus”) for total consideration of $128.9 million with contingent consideration of up to $132.5 million payable based on the achievement of certain regulatory and sales milestones.